ENDOSCOPIC ULTRASOUND; HIGHLY EFFECTIVE IN THE INVESTIGATION OF LYMPHADENOPATHY OF UNKNOWN CAUSE

Aims Endoscopic ultrasound (EUS) guided tissue acquisition is an indispensable tool in the diagnostic pathway of upper GI and hepatobiliary cancer. We sought to assess the utility in guiding patient management in patients presenting with lymphadenopathy of unknown cause.

Methods Consecutive patients with lymphadenopathy undergoing EUS guided lymph node sampling were retrospectively analysed. Recorded variables included patient demographics, procedural characteristics, histological findings and patient management.

Results 90 episodes (males n=51, 57%) were identified over a ten-year period. Median age at EUS was 62 years old (range 13-88 years old). Median size of lymph node sampled was 20mm (range 6-71mm), with a median of 2 passes (range 1-4). A 22 G needle was used in 62 (68.89%) of cases.

The majority of lymph nodes sampled were from the peri-pancreatic area (n=50, 56%), followed by peri-hepatic (n=15, 17%), celiac (n=14, 16%), para-esophageal (n=4, 4.%), peri-gastric (n=3, 3%), mediastinum (n=2, 2%) and para-duodenal (n=2, 2%).

The final diagnosis were benign lymphadenopathy (n=31, 34%) followed by adenocarcinoma (n=23, 26%), lymphoma (n=6, 7%), tuberculosis (TB) (n=5, 6%), Sarcoid (n=5, 6%), and neuroendocrine tumour (n=5, 6%). There was insufficient tissue for histological diagnosis in 15 (17%) cases. Sensitivity for malignancy was 78% with a specificity of 100%. Sensitivity for inflammatory disorders was 88%. All the cases with tuberculosis had a positive diagnosis. There were no complications associated with EUS guided sampling.

Conclusions EUS is a highly safe and effective method of tissue acquisition in patient presenting with unexplained lymphadenopathy.

Publication History

Article published online:
14 April 2022